Author:
Charalampidou S,Nolan J,Ormonde G O,Beatty S
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355 (14): 1419–1431.
2. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T . Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study. Ophthalmology 2009; 116 (1): 57–65.e5.
3. Lantry LE . Ranibizumab, a mAb against VEGF-A for the potential treatment of age-related macular degeneration and other ocular complications. Curr Opin Mol Ther 2007; 9 (6): 592–602.
4. Querques G, Bux AV, Martinelli D, Iaculli C, Noci ND . Intravitreal pegaptanib sodium (Macugen) for diabetic macular oedema. Acta Ophthalmol 2009; 87 (6): 623–630.
5. Yilmaz T, Weaver CD, Gallagher MJ, Cordero-Coma M, Cervantes-Castaneda RA, Klisovic D et al. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology 2009; 116 (5): 902–911; quiz 912–913.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献